TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UCB Pharma Oy Finland
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
163,926
|
167,627
|
158,890 |
| Financial expenses |
409
|
335
|
235 |
| Earnings before taxes |
7,160
|
4,445
|
5,791 |
| Total assets |
74,053
|
72,237
|
57,050 |
| Current assets |
11,049
|
14,960
|
2,932 |
| Current liabilities |
42,260
|
33,686
|
51,069 |
| Equity capital |
7,387
|
5,229
|
5,972 |
| - share capital |
73
|
76
|
72 |
| Employees (average) |
14
|
16
|
18 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
10.0%
|
7.2%
|
10.5% |
| Turnover per employee |
11,709
|
10,477
|
8,827 |
| Profit as a percentage of turnover |
4.4%
|
2.7%
|
3.6% |
| Return on assets (ROA) |
10.2%
|
6.6%
|
10.6% |
| Current ratio |
26.1%
|
44.4%
|
5.7% |
| Return on equity (ROE) |
96.9%
|
85.0%
|
97.0% |
| Change turnover |
4,589
|
-229
|
5,972 |
| Change turnover % |
3%
|
0%
|
4% |
| Chg. No. of employees |
-2
|
-2
|
-1 |
| Chg. No. of employees % |
-13%
|
-11%
|
-5% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.